CI Security, a managed detection and response (MDR) provider, has secured Series B financing from healthcare investment firm Concord Health Partners, bringing its total Series B funding to $16 million.
CI Security will use the new funding to explore ways to accelerate its growth in the healthcare market; this segment is expected to expand at a compound annual growth rate of 19.1 percent between 2019 and 2025, research firm Global Market Insights has projected.
CI provides healthcare organizations with network visibility to help them manage data and comply with HIPAA requirements, the company said. It also delivers threat monitoring capabilities backed by security operations centers (SOCs).
Furthermore, CI offers an agentless MDR solution that allows healthcare organizations to monitor connected medical devices without causing interference, the company indicated. The solution ensures that healthcare organizations can secure protected health information (PHI) and personally identifiable information (PII) on premises.
Introducing CI Rapid Quarantine Solutions
CI's Series B funding comes after the company in June 2019 unveiled its Critical Insight Rapid Quarantine (CIRQ) active containment solutions to help organizations detect and address cyberattacks.
CIRQ enables organizations to quarantine infected systems after cyber threats are detected, along with reduce the time required to detect and respond to cyberattacks, CI stated. It also allows organizations to collaborate with CI security analysts who help define security parameters for identifying and containing cyberattacks.
